Novel Coronavirus risks a resurgence in popularity in China

On June 4, the Lancet published online a public health strategy and policy paper by Gao’s team and Professor Feng Zijian.
The article describes China’s strategies and experience in fighting the epidemic.

The article was published in the Health Policy section of The Lancet, which is a content of experience and policy analysis. The article is more about the review and analysis of existing experience, as well as the prediction of future trends. It does not involve treatment regimens or other contents.

There are many notable points.

China’s whole population has an infection fatality ratio of 0.66 percent.

Given that the vast majority of people in China are still generally susceptible to COVID-19, China is at risk of another COVID-19 epidemic.

If the COVID-19 pandemic continues to worsen, it could cause an estimated 50 to 100 million deaths globally.

Thanks to repression and containment, China has brought the epidemic under control, hoping that the vaccine will develop herd immunity.

A slow epidemic may achieve herd immunity over a long period of time, but at a high cost in terms of morbidity and mortality.